 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
| «12 |
- ||||||| Audenz (influenza A (H5N1) monovalent vaccine adjuvanted) / CSL Behring
Trial completion: Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Underlying Medical Conditions (clinicaltrials.gov) - Apr 14, 2015
P3, N=540, Completed, Sponsor: Novartis Vaccines
Active, not recruiting --> Completed
- ||||| Audenz (influenza A (H5N1) monovalent vaccine adjuvanted) / CSL Behring
Enrollment closed: Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine (clinicaltrials.gov) - Jan 15, 2015
P3, N=540, Active, not recruiting, Sponsor: Novartis
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- ||||| Audenz (influenza A (H5N1) monovalent vaccine adjuvanted) / CSL Behring
Enrollment closed: Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Underlying Medical Conditions (clinicaltrials.gov) - Oct 10, 2014
P3, N=540, Active, not recruiting, Sponsor: Novartis Vaccines
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- |||||| Audenz (influenza A (H5N1) monovalent vaccine adjuvanted) / CSL Behring
Enrollment open: Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine (clinicaltrials.gov) - Apr 24, 2014
P3, N=540, Recruiting, Sponsor: Novartis
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- |||||| Audenz (influenza A (H5N1) monovalent vaccine adjuvanted) / CSL Behring
Enrollment open: Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Underlying Medical Conditions (clinicaltrials.gov) - Apr 14, 2014
P3, N=540, Recruiting, Sponsor: Novartis Vaccines
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- |||||||||| Audenz (influenza A (H5N1) monovalent vaccine adjuvanted) / CSL Behring
New P3 trial: Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine (clinicaltrials.gov) - Apr 6, 2014
P3, N=540, Recruiting, Sponsor: Novartis
- |||||||||| Audenz (influenza A (H5N1) monovalent vaccine adjuvanted) / CSL Behring
New P3 trial: Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Underlying Medical Conditions (clinicaltrials.gov) - Mar 17, 2014
P3, N=540, Recruiting, Sponsor: Novartis Vaccines